Serum levels of RFC2, HSP90AB1, YWHAZ, CYP2E1, and ADH4 were measured by ELISA in 30 HCC patients and 30 healthy controls to validate differential expression at the protein level. This evidence concerns the gene RFC2 and hepatocellular carcinoma.